Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis
about
Studies of Immune Responses in Candida vaginitisProtection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherenceWild-type Drosophila melanogaster as a model host to analyze nitrogen source dependent virulence of Candida albicans.Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors.Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunityProspects for development of a vaccine to prevent and control vaginal candidiasis.Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions.Anticandidal immunity and vaginitis: novel opportunities for immune intervention.Candida, still number one--what do we know and where are we going from there?Vaccines in the treatment of invasive candidiasis.A novel glyco-conjugate vaccine against fungal pathogens.Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine.Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8⁺ T Lymphocytes in the Female Reproductive Tract.Transcriptional profiling of the Candida albicans Ssk1p receiver domain point mutants and their virulence.Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.Influenza virosomes as a vaccine adjuvant and carrier system.Advanced topical drug delivery system for the management of vaginal candidiasis.Adjuvants and delivery systems for antifungal vaccines: current state and future developments.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Future therapies targeted towards eliminating Candida biofilms and associated infections.Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasisProtection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future.
P2860
Q26782272-5672FE10-2730-451C-9CB5-39FF6D25D9A2Q30862390-33E6B5A0-B145-49EE-A028-E83F7A1F4CF1Q34081541-CBAD8414-9DF7-4BC7-A125-232930EE3167Q34130381-6EB00747-921E-40C0-932B-D362A281D019Q34415303-B11FD252-60A1-4033-B7B1-115569EA6AB9Q34707478-39BE1F11-17E0-4F14-A3A8-5E392157B0CFQ34720954-B51CEC8D-0CA0-48B4-873A-1E3922AB2CD6Q35624490-26E77324-D21D-4BAE-A72C-48242FE0980FQ36097307-6508B6E9-43B9-4051-BDCA-9D9CAC95A025Q36123883-3EA13C8D-9A15-4F18-965A-CE48FA60C8DEQ36147010-3347F3C6-B3CC-439E-9950-C3D87D6CDC30Q36402820-0F9C0ABC-D519-4834-88B2-B717C60D6683Q36690302-CD1FB9F8-1EAF-4B34-BC6C-269A1A4084DBQ36735275-1011B519-A419-451F-ACFC-3EAA3339F4F9Q36958271-7C5F9BC1-D650-425B-B3CC-290B093AB568Q37086092-8F5D7D5B-57D5-4B18-9AB5-AA8E8B873326Q37867100-83358B4D-AF40-48B0-A03E-24AE1D17446DQ38222794-F1D103B5-D09F-4D9F-9E85-87A21FF540CFQ38264288-57140DDD-EF40-49B5-BB8A-FCDCAB86DDEDQ38696236-81DA24B5-048E-49E2-92A5-11382578E892Q38786061-6DF2A102-375C-4C9A-A736-146834CC1E03Q42375553-1FC4DEAC-7BC4-46CF-A0DB-C7E60E92DBC3Q44792128-513AF84F-7E8F-4993-988F-936D3C352E7AQ53683158-B1DCF03F-E22A-4D61-ABA4-079509A8DD37
P2860
Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Intravaginal and intranasal im ...... on against vaginal candidiasis
@ast
Intravaginal and intranasal im ...... on against vaginal candidiasis
@en
Intravaginal and intranasal im ...... on against vaginal candidiasis
@nl
type
label
Intravaginal and intranasal im ...... on against vaginal candidiasis
@ast
Intravaginal and intranasal im ...... on against vaginal candidiasis
@en
Intravaginal and intranasal im ...... on against vaginal candidiasis
@nl
prefLabel
Intravaginal and intranasal im ...... on against vaginal candidiasis
@ast
Intravaginal and intranasal im ...... on against vaginal candidiasis
@en
Intravaginal and intranasal im ...... on against vaginal candidiasis
@nl
P2093
P2860
P1476
Intravaginal and intranasal im ...... on against vaginal candidiasis
@en
P2093
Antonietta Girolamo
Antonio Cassone
Daniela Adriani
Flavia De Bernardis
Maria Boccanera
P2860
P304
P356
10.1128/IAI.70.5.2725-2729.2002
P407
P577
2002-05-01T00:00:00Z